Open AccessCommentary on Phosphodiesterase 5 Inhibitor Mirodenafil Ameliorates Alzheimer-Like Pathology and Symptoms by Multimodal Actions
Author(s) -
David Greeley
Publication year - 2022
Publication title -
applied cell biology
Language(s) - English
Resource type - Journals
eISSN - 2320-1991
pISSN - 2320-1983
DOI - 10.53043/2320-1991.acb90032
Subject(s) - phosphodiesterase , cgmp specific phosphodiesterase type 5 , medicine , neuroscience , pharmacology , psychology , chemistry , enzyme , sildenafil , biochemistry